Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission - Université de Bretagne Occidentale Access content directly
Conference Poster Year : 2019

Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission

Domains

Immunology
No file

Dates and versions

hal-02158682 , version 1 (18-06-2019)

Identifiers

  • HAL Id : hal-02158682 , version 1

Cite

Kedra Joanna, Philippe Dieudé, Hubert Marotte, Alexandre Lafourcade, Emilie Ducourau, et al.. Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02158682⟩
160 View
0 Download

Share

Gmail Facebook X LinkedIn More